Document is current
Any future updates will be listed below
-
Authors
Takaku, Ruriko
Nakano, Shinichiro
Iida, Masaharu
Oshika, Tetsuro
- License Information
-
More Information
Article History
Received: 24 April 2021
Accepted: 1 July 2021
First Online: 23 July 2021
Competing interests
: Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, and Mitsubishi Tanabe. He receives research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Pfizer, and Topcon. Other authors do not have any conflict of interest.
